已收盤 02-06 16:00:00 美东时间
+0.050
+0.84%
今日重点评级关注:Ascendiant Capital:维持GRI Bio"买入"评级,目标价从35美元升至36美元;Ascendiant Capital:维持Atossa Therapeutics"买入"评级,目标价从7.75美元升至8美元
2025-12-09 10:32
今日重点评级关注:摩根士丹利:维持Kyverna Therapeutics"超配"评级,目标价从20美元升至25美元;Maxim Group:维持Capricor Therapeutics"买入"评级,目标价从25美元升至50美元
2025-12-05 08:35
Rosenblatt analyst Catharine Trebnick maintains Sprinklr (NYSE:CXM) with a Buy and maintains $12 price target.
2025-12-05 01:15
Sprinklr (NYSE: CXM) stock gains after reporting Q3 2026 results with $219.068 million sales and 12 cents adjusted EPS, exceeding estimates.
2025-12-03 22:06
Companies Reporting Before The Bell • Yuanbao (NASDAQ:YB) is likely to report e...
2025-12-03 19:11
Sprinklr (NYSE:CXM) will release its quarterly earnings report on Wednesday, 20...
2025-12-02 23:01
今日重点评级关注:巴克莱:维持Iovance Biotherapeutics"超配"评级,目标价从4美元升至9美元;BTIG:维持Cullinan Therapeutics"买入"评级,目标价从32美元升至38美元
2025-11-25 10:27
Citigroup analyst Tyler Radke maintains Sprinklr (NYSE:CXM) with a Neutral and lowers the price target from $9 to $8.
2025-11-25 02:51
The latest announcement is out from Sprinklr ( ($CXM) ). On November 7, 2025, S...
2025-11-12 21:20
Sprinklr (NYSE:CXM) said that Anthony Coletta will join the firm as Chief Financial Officer, effective immediately. Coletta most recently, he served as Chief Investor Relations Officer at SAP SE. Prio...
2025-10-07 20:03